| Abstract | p. i |
| Editorial | p. 6 |
| Preface | p. 8 |
| Introduction | p. 11 |
| What is the purpose of this report? | p. 12 |
| What is remote high dose rate brachytherapy? | p. 13 |
| Current Clinical Use of HDR brachytherapy | p. 15 |
| Infrastructure and Components of the Remote Afterloading HDR suite | p. 16 |
| HDR Suite | p. 17 |
| HDR Unit | p. 18 |
| HDR source | p. 18 |
| Afterloader device (treatment unit) | p. 19 |
| Control console | p. 20 |
| Applicators | p. 20 |
| Treatment Planning System | p. 21 |
| Preplanning | p. 22 |
| Individualised planning | p. 22 |
| Associated safety devices | p. 22 |
| Building | p. 23 |
| Infrastructure required for applicator/catheter placement (procedure room) | p. 23 |
| Infrastructure required for localisation radiographs | p. 23 |
| Infrastructure required for the treatment planning room | p. 24 |
| Infrastructure required for the treatment room | p. 24 |
| Imaging | p. 24 |
| Equipment for radiation safety and source handling | p. 25 |
| Personnel Requirements and Training | p. 26 |
| Personnel requirements | p. 26 |
| Radiation oncologist | p. 26 |
| Medical physicist | p. 27 |
| Technician / Brachytherapy technologist | p. 28 |
| Nurse | p. 28 |
| Is there need for special training for HDR procedures? | p. 29 |
| Radiation oncologist training | p. 29 |
| Physicist training | p. 29 |
| Technician and nurse training | p. 30 |
| Emergency procedures | p. 30 |
| Quality Assurance (QA) | p. 31 |
| Clinical QA | p. 31 |
| Physical quality assurance | p. 31 |
| Organisational quality assurance | p. 32 |
| Specific QA related to HDR units | p. 32 |
| Special requirements for interstitial brachytherapy | p. 32 |
| Exposures, Events, and Accidents | p. 33 |
| Events related to packing and transport | p. 33 |
| Exposures to personnel and public | p. 34 |
| Events during operation | p. 34 |
| Reported mechanical and computer events | p. 34 |
| Reported human errors | p. 35 |
| Examples of reported events | p. 37 |
| The most severe case | p. 37 |
| Transport and package | p. 37 |
| Source placed outside the transport safe and not secured | p. 37 |
| Returned source not inserted in safe: failure to survey | p. 38 |
| Damage in transit | p. 38 |
| Exposure to personnel and public | p. 39 |
| Inadequate shielding of bunker | p. 39 |
| Faulty connection from transport container to HDR safe | p. 39 |
| Mechanical events | p. 39 |
| Source cable separated from drive unit | p. 39 |
| Source stuck (unknown reason) | p. 40 |
| Undersized transfer cable diameter | p. 40 |
| Treatment planning software error / or human error | p. 41 |
| Kink in the applicator (needle) | p. 42 |
| Failure of retraction system | p. 43 |
| Loss of connection between control panel and HDR unit | p. 43 |
| Optical interlock | p. 43 |
| Open-ended source carrier | p. 44 |
| Human errors | p. 44 |
| Wrong patient: Identification problem | p. 44 |
| Reverse order of entry of dwell positions | p. 44 |
| Inadequate default position for start of dwell sites | p. 45 |
| Kink in catheter | p. 46 |
| Dwell position error | p. 46 |
| Wrong catheter | p. 47 |
| Wrong length catheter | p. 47 |
| Wrong orifice | p. 47 |
| Wrong transfer tube | p. 48 |
| Failure to recalibrate | p. 48 |
| Dislodged applicator | p. 49 |
| Recommendations | p. 50 |
| General | p. 50 |
| Specific | p. 50 |
| Clinical Indications | p. 53 |
| Cervical cancer | p. 53 |
| Carcinoma of the endometrium | p. 54 |
| Oesophageal cancer | p. 54 |
| Head and neck cancer | p. 55 |
| Nasopharynx | p. 55 |
| Other interstitial or mould applications | p. 55 |
| Lung cancer | p. 55 |
| Breast | p. 56 |
| Prostate | p. 56 |
| Soft tissue sarcomas | p. 57 |
| Soft tissue sarcomas in children | p. 58 |
| Other sites | p. 59 |
| Intraoperative use of HDR brachytherapy | p. 59 |
| References | p. 60 |
| Table of Contents provided by Publisher. All Rights Reserved. |